CU6 2.71% $7.20 clarity pharmaceuticals ltd

Ann: Theranostic prostate cancer trial advances to multi-dose, page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 19,434 Posts.
    lightbulb Created with Sketch. 6528
    They would only require 255Ac is used first if it an approved treatment at the time the Phase 3 starts. The best outcome would be a head-to-head against 177Lu in a theranostic-naïve population.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$7.20
Change
0.190(2.71%)
Mkt cap ! $2.305B
Open High Low Value Volume
$7.12 $7.34 $6.95 $5.698M 788.1K

Buyers (Bids)

No. Vol. Price($)
4 16776 $7.20
 

Sellers (Offers)

Price($) Vol. No.
$7.27 197 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.